Patents by Inventor Jun Y. AXUP

Jun Y. AXUP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF
    Publication number: 20220396621
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, coreceptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: June 22, 2022
    Publication date: December 15, 2022
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Hwayoung YUN, Peter G. SCHULTZ, Jennifer MA, Jiayin SHEN, Pengyu YANG
  • Targeting agent antibody conjugates and uses thereof
    Patent number: 11377496
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: July 5, 2022
    Assignee: THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Chanhyuk Kim, Jun Y. Axup, Hwayoung Yun, Peter G. Schultz, Jennifer Ma, Jiayin Shen, Pengyu Yang
  • TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF
    Publication number: 20190315863
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: May 22, 2019
    Publication date: October 17, 2019
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Hwayoung YUN, Peter G. SCHULTZ, Jennifer MA, Jiayin SHEN, Pengyu YANG
  • Targeting agent antibody conjugates and uses thereof
    Patent number: 10351626
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: July 16, 2019
    Assignee: The Scripps Research Institute
    Inventors: Chanhyuk Kim, Jun Y. Axup, Hwayoung Yun, Peter G. Schultz, Jennifer Ma, Jiayin Shen, Pengyu Yang
  • TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF
    Publication number: 20170002076
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: September 16, 2016
    Publication date: January 5, 2017
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Hwayoung YUN, Peter G. SCHULTZ, Jennifer MA, Jiayin SHEN, Pengyu YANG
  • TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF
    Publication number: 20160115232
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: March 14, 2014
    Publication date: April 28, 2016
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Hwayoung YUN, Peter G. SCHULTZ, Jennifer MA, Jiayin SHEN, Pengyu YANG
  • BISPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20160017058
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 21, 2016
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Peter G. SCHULTZ, Travis YOUNG, Stephanie PINKERTON, Quan ZHOU, Yu CAO